CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
- Country
- ๐ฌ๐งUnited Kingdom
- Ownership
- Subsidiary
- Established
- 1992-11-04
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.cuh.org.uk
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
- Conditions
- SARS-CoV-2Quality of LifeCOVID19AnosmiaOlfactory DisorderSmell DisorderMicrosomia
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-12-14
- Target Recruit Count
- 90
- Registration Number
- NCT04466982
- Locations
- ๐ฌ๐ง
Addenbrookes Hospital, Cambridge, United Kingdom
๐ฌ๐งRoyal Cornwall Hospital, Truro, United Kingdom
๐ฌ๐งCharing Cross Hospital, London, United Kingdom
Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19)
- Conditions
- COVID-19
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-07-28
- Target Recruit Count
- 200
- Registration Number
- NCT04432961
- Locations
- ๐ฌ๐ง
Cambridge University NHS Foundation Trust, Cambridge, United Kingdom
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2023-07-28
- Target Recruit Count
- 454
- Registration Number
- NCT04393246
- Locations
- ๐ฌ๐ง
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R)
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2020-05-18
- Target Recruit Count
- 1167
- Registration Number
- NCT04390464
- Locations
- ๐ฌ๐ง
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
PROLIFIC ChemoprophylaxisTrial (COVID-19)
- Conditions
- COVID-19
- Interventions
- Other: Matched Placebo Hydroxychloroquine
- First Posted Date
- 2020-04-20
- Last Posted Date
- 2020-05-13
- Target Recruit Count
- 1000
- Registration Number
- NCT04352933
- Locations
- ๐ฌ๐ง
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes
- Conditions
- Type 2 DiabetesObesity
- First Posted Date
- 2020-03-13
- Last Posted Date
- 2022-02-01
- Target Recruit Count
- 16
- Registration Number
- NCT04307797
- Locations
- ๐ฌ๐ง
Cambridge University Hospitals NHS Foundation Trust and The University of Cambridge, Cambridge, Cambridgeshire, United Kingdom
Clinical Evaluation of the Hemosonics Quantraยฎ Coagulation Monitor in Liver and Multivisceral Transplantation
- Conditions
- CoagulopathyLiver Transplantation
Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY
- Conditions
- Acute Coronary Syndromes
- Interventions
- Other: Placebo Dextrose 5% solution
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2024-06-10
- Target Recruit Count
- 60
- Registration Number
- NCT04241601
- Locations
- ๐ฌ๐ง
Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom
Neonatal Wireless Monitoring System for Intensive Care
- Conditions
- Low; Birthweight, Extremely (999 Grams or Less)Preterm InfantInfant, Newborn
- Interventions
- Device: Wireless vital sign monitoring - comparativeDevice: Wireless vital sign monitoring - usability
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2021-01-12
- Target Recruit Count
- 20
- Registration Number
- NCT04241263
- Locations
- ๐ฌ๐ง
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom